KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Net Margin (2018 - 2025)

Historic Net Margin for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to 5.14%.

  • BioNTech SE's Net Margin fell 107700.0% to 5.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.12%, marking a year-over-year decrease of 154200.0%. This contributed to the annual value of 25.08% for FY2024, which is 628400.0% down from last year.
  • Latest data reveals that BioNTech SE reported Net Margin of 5.14% as of Q3 2025, which was down 107700.0% from 160.58% recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Net Margin ranged from a high of 99.42% in Q1 2022 and a low of 624.55% during Q2 2024
  • Its 5-year average for Net Margin is 33.12%, with a median of 21.81% in 2024.
  • As far as peak fluctuations go, BioNTech SE's Net Margin crashed by -5110200bps in 2024, and later soared by 4639700bps in 2025.
  • Quarter analysis of 5 years shows BioNTech SE's Net Margin stood at 0.0% in 2021, then soared by 93067603bps to 53.26% in 2022, then grew by 10bps to 58.72% in 2023, then tumbled by -63bps to 21.81% in 2024, then crashed by -76bps to 5.14% in 2025.
  • Its Net Margin stands at 5.14% for Q3 2025, versus 160.58% for Q2 2025 and 259.85% for Q1 2025.